List of Tables
Table 1. AAV Vector Gene Therapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. AAV Vector Gene Therapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of AAV1
Table 4. Major Players of AAV2
Table 5. Major Players of AAV8
Table 6. Major Players of Other
Table 7. Global AAV Vector Gene Therapy Sales by Type (2018-2023) & (K Units)
Table 8. Global AAV Vector Gene Therapy Sales Market Share by Type (2018-2023)
Table 9. Global AAV Vector Gene Therapy Revenue by Type (2018-2023) & ($ million)
Table 10. Global AAV Vector Gene Therapy Revenue Market Share by Type (2018-2023)
Table 11. Global AAV Vector Gene Therapy Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global AAV Vector Gene Therapy Sales by Application (2018-2023) & (K Units)
Table 13. Global AAV Vector Gene Therapy Sales Market Share by Application (2018-2023)
Table 14. Global AAV Vector Gene Therapy Revenue by Application (2018-2023)
Table 15. Global AAV Vector Gene Therapy Revenue Market Share by Application (2018-2023)
Table 16. Global AAV Vector Gene Therapy Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global AAV Vector Gene Therapy Sales by Company (2018-2023) & (K Units)
Table 18. Global AAV Vector Gene Therapy Sales Market Share by Company (2018-2023)
Table 19. Global AAV Vector Gene Therapy Revenue by Company (2018-2023) ($ Millions)
Table 20. Global AAV Vector Gene Therapy Revenue Market Share by Company (2018-2023)
Table 21. Global AAV Vector Gene Therapy Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers AAV Vector Gene Therapy Producing Area Distribution and Sales Area
Table 23. Players AAV Vector Gene Therapy Products Offered
Table 24. AAV Vector Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global AAV Vector Gene Therapy Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global AAV Vector Gene Therapy Sales Market Share Geographic Region (2018-2023)
Table 29. Global AAV Vector Gene Therapy Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global AAV Vector Gene Therapy Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global AAV Vector Gene Therapy Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global AAV Vector Gene Therapy Sales Market Share by Country/Region (2018-2023)
Table 33. Global AAV Vector Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global AAV Vector Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas AAV Vector Gene Therapy Sales by Country (2018-2023) & (K Units)
Table 36. Americas AAV Vector Gene Therapy Sales Market Share by Country (2018-2023)
Table 37. Americas AAV Vector Gene Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas AAV Vector Gene Therapy Revenue Market Share by Country (2018-2023)
Table 39. Americas AAV Vector Gene Therapy Sales by Type (2018-2023) & (K Units)
Table 40. Americas AAV Vector Gene Therapy Sales by Application (2018-2023) & (K Units)
Table 41. APAC AAV Vector Gene Therapy Sales by Region (2018-2023) & (K Units)
Table 42. APAC AAV Vector Gene Therapy Sales Market Share by Region (2018-2023)
Table 43. APAC AAV Vector Gene Therapy Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC AAV Vector Gene Therapy Revenue Market Share by Region (2018-2023)
Table 45. APAC AAV Vector Gene Therapy Sales by Type (2018-2023) & (K Units)
Table 46. APAC AAV Vector Gene Therapy Sales by Application (2018-2023) & (K Units)
Table 47. Europe AAV Vector Gene Therapy Sales by Country (2018-2023) & (K Units)
Table 48. Europe AAV Vector Gene Therapy Sales Market Share by Country (2018-2023)
Table 49. Europe AAV Vector Gene Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe AAV Vector Gene Therapy Revenue Market Share by Country (2018-2023)
Table 51. Europe AAV Vector Gene Therapy Sales by Type (2018-2023) & (K Units)
Table 52. Europe AAV Vector Gene Therapy Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa AAV Vector Gene Therapy Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa AAV Vector Gene Therapy Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa AAV Vector Gene Therapy Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa AAV Vector Gene Therapy Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa AAV Vector Gene Therapy Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa AAV Vector Gene Therapy Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of AAV Vector Gene Therapy
Table 60. Key Market Challenges & Risks of AAV Vector Gene Therapy
Table 61. Key Industry Trends of AAV Vector Gene Therapy
Table 62. AAV Vector Gene Therapy Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. AAV Vector Gene Therapy Distributors List
Table 65. AAV Vector Gene Therapy Customer List
Table 66. Global AAV Vector Gene Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global AAV Vector Gene Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas AAV Vector Gene Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas AAV Vector Gene Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC AAV Vector Gene Therapy Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC AAV Vector Gene Therapy Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe AAV Vector Gene Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe AAV Vector Gene Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa AAV Vector Gene Therapy Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa AAV Vector Gene Therapy Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global AAV Vector Gene Therapy Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global AAV Vector Gene Therapy Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global AAV Vector Gene Therapy Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global AAV Vector Gene Therapy Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. uniQure Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 81. uniQure AAV Vector Gene Therapy Product Portfolios and Specifications
Table 82. uniQure AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. uniQure Main Business
Table 84. uniQure Latest Developments
Table 85. Roche Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche AAV Vector Gene Therapy Product Portfolios and Specifications
Table 87. Roche AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. Novartis Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 91. Novartis AAV Vector Gene Therapy Product Portfolios and Specifications
Table 92. Novartis AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Novartis Main Business
Table 94. Novartis Latest Developments
Table 95. BioMarin Pharmaceutical Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 96. BioMarin Pharmaceutical AAV Vector Gene Therapy Product Portfolios and Specifications
Table 97. BioMarin Pharmaceutical AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BioMarin Pharmaceutical Main Business
Table 99. BioMarin Pharmaceutical Latest Developments
Table 100. Ferring Pharmaceuticals A/S Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 101. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product Portfolios and Specifications
Table 102. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ferring Pharmaceuticals A/S Main Business
Table 104. Ferring Pharmaceuticals A/S Latest Developments
Table 105. CSL Behring LLC Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Behring LLC AAV Vector Gene Therapy Product Portfolios and Specifications
Table 107. CSL Behring LLC AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. CSL Behring LLC Main Business
Table 109. CSL Behring LLC Latest Developments
Table 110. PTC Therapeutics, Inc. Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 111. PTC Therapeutics, Inc. AAV Vector Gene Therapy Product Portfolios and Specifications
Table 112. PTC Therapeutics, Inc. AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. PTC Therapeutics, Inc. Main Business
Table 114. PTC Therapeutics, Inc. Latest Developments
Table 115. Pfizer Inc. Basic Information, AAV Vector Gene Therapy Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Inc. AAV Vector Gene Therapy Product Portfolios and Specifications
Table 117. Pfizer Inc. AAV Vector Gene Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pfizer Inc. Main Business
Table 119. Pfizer Inc. Latest Developments

LIST OF FIGURE

List of Figures
Figure 1. Picture of AAV Vector Gene Therapy
Figure 2. AAV Vector Gene Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AAV Vector Gene Therapy Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global AAV Vector Gene Therapy Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. AAV Vector Gene Therapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of AAV1
Figure 10. Product Picture of AAV2
Figure 11. Product Picture of AAV8
Figure 12. Product Picture of Other
Figure 13. Global AAV Vector Gene Therapy Sales Market Share by Type in 2022
Figure 14. Global AAV Vector Gene Therapy Revenue Market Share by Type (2018-2023)
Figure 15. AAV Vector Gene Therapy Consumed in Duchenne Dystrophy
Figure 16. Global AAV Vector Gene Therapy Market: Duchenne Dystrophy (2018-2023) & (K Units)
Figure 17. AAV Vector Gene Therapy Consumed in Hemophilia
Figure 18. Global AAV Vector Gene Therapy Market: Hemophilia (2018-2023) & (K Units)
Figure 19. AAV Vector Gene Therapy Consumed in Retinal Diseases
Figure 20. Global AAV Vector Gene Therapy Market: Retinal Diseases (2018-2023) & (K Units)
Figure 21. AAV Vector Gene Therapy Consumed in Other
Figure 22. Global AAV Vector Gene Therapy Market: Other (2018-2023) & (K Units)
Figure 23. Global AAV Vector Gene Therapy Sales Market Share by Application (2022)
Figure 24. Global AAV Vector Gene Therapy Revenue Market Share by Application in 2022
Figure 25. AAV Vector Gene Therapy Sales Market by Company in 2022 (K Units)
Figure 26. Global AAV Vector Gene Therapy Sales Market Share by Company in 2022
Figure 27. AAV Vector Gene Therapy Revenue Market by Company in 2022 ($ Million)
Figure 28. Global AAV Vector Gene Therapy Revenue Market Share by Company in 2022
Figure 29. Global AAV Vector Gene Therapy Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global AAV Vector Gene Therapy Revenue Market Share by Geographic Region in 2022
Figure 31. Americas AAV Vector Gene Therapy Sales 2018-2023 (K Units)
Figure 32. Americas AAV Vector Gene Therapy Revenue 2018-2023 ($ Millions)
Figure 33. APAC AAV Vector Gene Therapy Sales 2018-2023 (K Units)
Figure 34. APAC AAV Vector Gene Therapy Revenue 2018-2023 ($ Millions)
Figure 35. Europe AAV Vector Gene Therapy Sales 2018-2023 (K Units)
Figure 36. Europe AAV Vector Gene Therapy Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa AAV Vector Gene Therapy Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa AAV Vector Gene Therapy Revenue 2018-2023 ($ Millions)
Figure 39. Americas AAV Vector Gene Therapy Sales Market Share by Country in 2022
Figure 40. Americas AAV Vector Gene Therapy Revenue Market Share by Country in 2022
Figure 41. Americas AAV Vector Gene Therapy Sales Market Share by Type (2018-2023)
Figure 42. Americas AAV Vector Gene Therapy Sales Market Share by Application (2018-2023)
Figure 43. United States AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC AAV Vector Gene Therapy Sales Market Share by Region in 2022
Figure 48. APAC AAV Vector Gene Therapy Revenue Market Share by Regions in 2022
Figure 49. APAC AAV Vector Gene Therapy Sales Market Share by Type (2018-2023)
Figure 50. APAC AAV Vector Gene Therapy Sales Market Share by Application (2018-2023)
Figure 51. China AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 55. India AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe AAV Vector Gene Therapy Sales Market Share by Country in 2022
Figure 59. Europe AAV Vector Gene Therapy Revenue Market Share by Country in 2022
Figure 60. Europe AAV Vector Gene Therapy Sales Market Share by Type (2018-2023)
Figure 61. Europe AAV Vector Gene Therapy Sales Market Share by Application (2018-2023)
Figure 62. Germany AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 63. France AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa AAV Vector Gene Therapy Sales Market Share by Country in 2022
Figure 68. Middle East & Africa AAV Vector Gene Therapy Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa AAV Vector Gene Therapy Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa AAV Vector Gene Therapy Sales Market Share by Application (2018-2023)
Figure 71. Egypt AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country AAV Vector Gene Therapy Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of AAV Vector Gene Therapy in 2022
Figure 77. Manufacturing Process Analysis of AAV Vector Gene Therapy
Figure 78. Industry Chain Structure of AAV Vector Gene Therapy
Figure 79. Channels of Distribution
Figure 80. Global AAV Vector Gene Therapy Sales Market Forecast by Region (2024-2029)
Figure 81. Global AAV Vector Gene Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global AAV Vector Gene Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global AAV Vector Gene Therapy Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global AAV Vector Gene Therapy Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global AAV Vector Gene Therapy Revenue Market Share Forecast by Application (2024-2029)